Chemopreventive potential of methanol extract of Dicranopteris linearis leaf on DMBA/croton oil-induced mouse skin carcinogenesis.
The present study was carried out to elucidate the chemopreventive potential of methanol extract of Dicranopteris linearis (MEDL) in a two-stage mouse skin carcinogenesis model due to the interrelated inflammation, oxidative stress and tumor promotion pathways. MEDL was prepared in a dose range of 3...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academic Journals
2013
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/29825/1/Chemopreventive%20potential%20of%20methanol%20extract%20of%20Dicranopteris%20linearis%20leaf%20on%20DMBA.pdf http://psasir.upm.edu.my/id/eprint/29825/ http://www.academicjournals.org/journal/AJPP/article-stat/250B79640539 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The present study was carried out to elucidate the chemopreventive potential of methanol extract of Dicranopteris linearis (MEDL) in a two-stage mouse skin carcinogenesis model due to the interrelated inflammation, oxidative stress and tumor promotion pathways. MEDL was prepared in a dose range of 30 to 300 mg/kg body weight. A total of 48 imprinting control region (ICR) female mice (6 to 8 weeks old) were randomly assorted into six groups. To induce skin tumor formation, a single topical application of
7,12-dimethylbenz[a]anthracene (DMBA) at 100 μg/100 μl was applied to the shaved dorsal region of mice, followed by repetitive administration of 1% croton oil, twice weekly for 15 weeks. Topical application of MEDL, 30 min prior to the croton oil application significantly reduced the tumor incidence to 12.5% in 300 mg/kg MEDL-treated group as compared to 87.5% in carcinogen control. The latency
period of tumor formation was increased from sixth week in the carcinogen control to ninth and fifteenth weeks in 100 and 300 mg/kg MEDL-treated groups, respectively. The tumor burden of MEDL-treated groups (30, 100, and 300 mg/kg) were significantly lessen (5.67 ± 1.28, 5.00 ± 1.13, and 1.00 ± 0.13), as compared to carcinogen control (7.86 ± 2.37). The tumor volume was also significantly reduced from 9.00 ± 2.27 mm3 in carcinogen control to 3.70 ± 0.96, 2.39 ± 0.54 and 0.26 ± 0.03 mm3 in 30, 100 and 300 mg/kg MEDL-treated groups, respectively. In conclusion, the MEDL exhibited anti-carcinogenic effect in a dose-dependent manner, indicating its chemopreventive potential, which worth further study.
|
|---|